FIREFLY NEUROSCIENCE, INC. (AIFF) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$1.26

From 52W high−59.34%

Volume1.63M

Market cap$19.46M

P/E (TTM)—

P/S (TTM)10.8x

Div yield—

Key dataSep 18, 2026

Open

$1.26

From 52W high

−59.34%

Volume

1.63M

Market cap

$19.46M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.2x

P/E (TTM)

—

RSI (14)

58.1

MomentumView details →

1D Return

−3.13%

YTD Return

+39.43%

SummaryUpdated Jun 1, 2026

Firefly Neuroscience, Inc. (NASDAQ:AIFF) is a Canadian medical technology and artificial intelligence company founded in 2002 and based in Toronto. The company develops neuroscientific solutions designed to improve diagnostic and treatment outcomes for patients suffering from mental illnesses and neurological disorders. Despite being publicly traded since 2002, Firefly remains in the early commercialization stage of its primary product offering, with minimal revenue generation and significant ongoing losses as it works to establish market presence in the specialized field of brain network analytics.

Ask drillr about FIREFLY NEUROSCIENCE, INC. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.2x

EV/Sales

5.7x

P/S (TTM)

10.8x

P/B (TTM)

1.3x

ProfitabilityView details →

Gross Margin

44.58%

Net Margin

−506.23%

EBITDA Margin

−493.11%

ROE (TTM)

−62.11%

ROA (TTM)

−54.31%

Asset Turnover

0.13x

GrowthView details →

Revenue YoY

+320.33%

EPS YoY

+78.35%

FCF YoY

+19.11%

Revenue CAGR 3Y

+51.43%

EPS CAGR 3Y

−16.25%

EBITDA YoY

+58.49%

MomentumView details →

1D Return

−3.13%

YTD Return

+39.43%

1Y Return

−57.79%

RSI (14)

58.1

vs 50D SMA

+10.02%

vs 200D SMA

−11.66%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

4.87x

Quick Ratio

4.85x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.80M

Net Income (TTM)

−9.11M

Op. CF (TTM)

−6.99M

Latest newsMore news →

Firefly Neuroscience's Evoke platform was selected to integrate objective brain-function insights into Radial's AI-native operating system for brain medicine.3d ago

Firefly Neuroscience, Inc. appointed Jessica Paz as Chief Accounting Officer, effective September 8, 2026, with a base salary of $215,000 and an option to purchase 50,000 shares.6d ago

Similar companies

Beamr Imaging Ltd.BMR The Glimpse Group, Inc.GGRP PSQ Holdings, Inc.PSQH MIND C.T.I. LtdMNDO Youxin Technology LtdYAAS Intelligent Protection Management Corp.IPM Find similar companies →

Latest newsMore news →

Firefly Neuroscience's Evoke platform was selected to integrate objective brain-function insights into Radial's AI-native operating system for brain medicine.3d ago Firefly Neuroscience, Inc. appointed Jessica Paz as Chief Accounting Officer, effective September 8, 2026, with a base salary of $215,000 and an option to purchase 50,000 shares.6d ago Firefly Neuroscience, Inc. terminated Chief Financial Officer Paul Krzywicki, effective September 24, 2026.6d ago